FDA warns of potential rare nerve complication with Johnson & Johnson coronavirus vaccine
The US Food and Drug Administration updated the label on Johnson & Johnson's coronavirus vaccine Monday to warn of the possible increased risk of a rare neurological complication called Guillain-Barré syndrome. While the FDA said it had not established the vaccine could cause the syndrome, it noted an increase in reports of the sometimes paralyzing condition. Read more
Let's look at the global statistics
Global infections: 187,355,083
Global deaths: 4,041,027
Vaccine doses administered: 3,479,804,410
Nations with most cases: US (33,890,833), India (30,874,376), Brazil (19,106,971),